B.R.I.D.G.E. TO DATA®
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
The Degge Group, Ltd. provides consulting services in pharmacoepidemiology, risk management, clinical drug safety, and pharmacovigilance to the pharmaceutical and medical product sector.
Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease, pharmacoeconomic and outcomes research, and recently risk evaluation and mitigation strategies (REMS).
Degge will help you identify and analyze key factors and find the right solution.
Earl Goehring Jr presented Real-Life Comparison of Dronedarone With Other Antiarrhythmic Drugs on Cardiovascular Outcomes in Atrial Fibrillation: An Updated Analysis of a Large US Population at a poster session during the 19th Annual AF Symposium held January 9-11, 2014 in Orlando, Florida.
Earl Goehring Jr, Managing Director celebrated his 15th year at Degge.
Anokhi Kapasi, PhD was recently promoted to Research Manager/Molecular Epidemiologist.
Arlene Tave, MA was recently promoted to Assisting Managing Director/Sr Data Analyst.
- Degge celebrates its 25th Anniversary of consulting in Drug Safety Research and Pharmacoepidemiology.
Judith K Jones, MD, PhD will be attending the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), March 18–22, 2014, at the Atlanta Marriott Marquis, Atlanta, Georgia.
The Degge Group, Ltd.
clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
1 (888) 413-3443
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069